Impax Laboratories to Present at the Cowen & Company 33rd Annual Health Care Conference
Impax Laboratories to Present at the Cowen & Company 33 rd Annual Health Care Conference
HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. today announced that the Company will present at the Cowen & Company 33rd Annual Health Care Conference on Wednesday, March 6, at 8:00 a.m. Eastern Standard Time. The conference will be held at The Boston Marriott Copley Place, Boston, MA.
Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.
Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Sr. Director, Investor Relations and Corporate Communications
KEYWORDS: United States North America California Massachusetts
The article Impax Laboratories to Present at the Cowen & Company 33rd Annual Health Care Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.